Pill Identifier results for 40 cy Round . Search by imprint, shape, color or drug name.
CY 40. Rosuvastatin Calcium Strength 40 mg Imprint CY 40 Color Pink Shape Round View details. 1 / 3 Loading. OC 20. Previous Next. OxyContin Strength 20 mg If your pill has no imprint it could be a vitamin, diet, herbal, or energy pill, or an illicit or foreign drug. It is not possible to accurately identify a pill online without an imprint
CY 5 Pill Images. The following drug pill images match your search criteria. Search Results; Search Again; Results 1 - 18 of 40 for CY 5 Sort by. Results per page. CY 5. Rosuvastatin Calcium Strength 5 mg Imprint CY 5 Color Pink Shape Round View details. CY 185. Doxycycline Hyclate Strength 100 mg Imprint CY 185 Color
View images of rosuvastatin and identify pills by imprint code, shape and color with the Drugs.com Pill Identifier. CY 40. Rosuvastatin Calcium Strength 40 mg
cy 40 Pill Images. The following drug pill images match your search criteria. Search Results; Search Again; Results 1 - 2 of 2 for cy 40 CY 40. Rosuvastatin Calcium Strength 40 mg Imprint CY 40 Color Pink Shape Round View details. 1 / 3 Loading. Pharmacia Upjohn EMCYT 140 mg. Previous Next. Emcyt Strength 140 mg Imprint Pharmacia Upjohn
Pill Identifier results for cy 40 Pink and Round . Search by imprint, shape, color or drug name.
Pill Identifier results for cy . Search by imprint, shape, color or drug name. CY 40 Color Pink Shape Round View details. CY 10. Rosuvastatin Calcium Strength 10 mg
This is a Tablet imprinted with CY on the front, 40 on the back. FACE MARKINGS: CY: REAR MARKINGS: 40: DOSE: 40 Mg: FORM: Tablet: Rosuvastatin Calcium Tablet 40 Mg.
CY 40 Pill - pink round, 9mm . Pill with imprint CY 40 is Pink, Round and has been identified as Rosuvastatin Calcium 40 mg. It is supplied by Tris Pharma Inc. Rosuvastatin is used in the treatment of Atherosclerosis; High Cholesterol; High Cholesterol, Familial Heterozygous; High Cholesterol, Familial Homozygous; Hyperlipoproteinemia and belongs to the drug class statins.
Comments